GUCY2D

GUCY2D Overview

English NameRetinal guanylyl cyclase 1Approved Drugs0
Drugs in Clinical Trials1Target SynonymRETGC-1,CG-E,Guanylate cyclase 2D, retinal,Rod outer segment membrane guanylate cyclase (ROS-GC),CORD6,GUC1A4,GUC2D,RETGC,RETGC1
Highest Development StagePhase 2 Clinical
English NameRetinal guanylyl cyclase 1
Target SynonymRETGC-1,CG-E,Guanylate cyclase 2D, retinal,Rod outer segment membrane guanylate cyclase (ROS-GC),CORD6,GUC1A4,GUC2D,RETGC,RETGC1
Approved Drugs0
Drugs in Clinical Trials1
Highest Development StagePhase 2 Clinical

GUCY2D Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    His Tag & Avi Tag (1)

  • Conjugate

    Biotin-labeled (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
GUD-H82E6
Human
HEK293
Biotinylated Human GUCY2D / Retinal guanylyl cyclase 1 Protein, His,Avitag™
Total: 1
  • 1

GUCY2D Background

GUCY2D also known as CORD6, GUC1A4, GUC2D ROS-GC and RETGC-1, belongs to the adenylyl cyclase class-4/guanylyl cyclase family. Catalyzes the synthesis of cyclic GMP (cGMP) in rods and cones of photoreceptors. Plays an essential role in phototransduction, by mediating cGMP replenishment. May also participate in the trafficking of membrane-asociated proteins to the photoreceptor outer segment membrane.

GUCY2D Synonyms

GUCY2D,Retinal guanylyl cyclase 1,RETGC-1,CORD6,GUC1A4,GUC2D,ROS-GC

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
ATSN-101SAR-439483; ATSN-101Phase 2 ClinicalUniversity Of FloridaLeber Congenital Amaurosis
Details
  • Product List
  • Clinical Drug Information